Mitchell Gillian, Sibley Paul E C, Wilson A Penelope M, Sauter Edward, A'Hern Roger, Eeles Rosalind A
Section of Cancer Genetics, Institute of Cancer Research, Sutton, UK.
Tumour Biol. 2002 Sep-Oct;23(5):287-97. doi: 10.1159/000068568.
To determine the variability of prostate-specific antigen (PSA) in the breast ductal fluid (nipple aspiration fluid, NAF) during the menstrual cycles of healthy premenopausal women.
Fifteen female volunteers underwent weekly nipple aspiration of ductal fluid from both breasts for the duration of two menstrual cycles. A highly sensitive and specific Third Generation PSA Assay (IMMULITE); Diagnostic Products Corporation, DPC) was used to detect NAF and serum PSA. Associations between NAF PSA and paired serum hormone levels of the pituitary-ovarian axis were tested using the Spearman rank correlation and the Wilcoxon signed rank test. Analysis of variance on log transformed NAF PSA was used to determine the intra- and intervolunteer variability.
NAF PSA ranged from <0.003 to 133,330 ng PSA/g total protein (median 2,030 ng/g). No repeatable pattern of change was observed for individual volunteers and no significant association between NAF PSA and any pituitary-ovarian axis serum hormone was detected. There was no correlation between serum and NAF PSA.
Weekly NAF sampling in healthy premenopausal women to provide adequate volumes for PSA analysis was successfully achieved. Considerable variation was observed for NAF PSA, which may limit the future potential for this tumor marker in NAF. This variability was not associated with hormones of the pituitary-ovarian axis and did not show repeated cyclical variability during the menstrual cycle. Serum PSA does not appear to be an acceptable indicator of NAF PSA levels.
确定健康绝经前女性月经周期中乳腺导管液(乳头抽吸液,NAF)中前列腺特异性抗原(PSA)的变异性。
15名女性志愿者在两个月经周期内每周对双侧乳房进行导管液乳头抽吸。使用高灵敏度和特异性的第三代PSA检测法(免疫化学发光法;诊断产品公司,DPC)检测NAF和血清PSA。使用Spearman秩相关和Wilcoxon符号秩检验来测试NAF PSA与垂体-卵巢轴配对血清激素水平之间的关联。对经对数转换的NAF PSA进行方差分析,以确定志愿者内部和志愿者之间的变异性。
NAF PSA范围为<0.003至133,330 ng PSA/克总蛋白(中位数为2,030 ng/g)。未观察到个体志愿者有可重复的变化模式,也未检测到NAF PSA与任何垂体-卵巢轴血清激素之间存在显著关联。血清和NAF PSA之间无相关性。
成功实现了对健康绝经前女性每周进行NAF采样,以提供足够量的样本用于PSA分析。观察到NAF PSA存在相当大的变异性,这可能会限制该肿瘤标志物在NAF中的未来应用潜力。这种变异性与垂体-卵巢轴的激素无关,在月经周期中也未显示出反复的周期性变化。血清PSA似乎不是NAF PSA水平的可接受指标。